FIELD: medicine.
SUBSTANCE: invention concerns chemical-pharmaceutical industry, namely development of a therapeutic agent for external application to be used for prevention of thromboses and disturbed circulation. The therapeutic agent represents nanostructured gel containing n-3 polyunsaturated fatty acids, α-tocopherol-acetate, phospholipid concentrate, alkali, water and liquid paraffin.
EFFECT: advantages of such composition are thermodynamic stability, possibility to introduce biologically active substances of both hydrophilic and amphiphilic, and hydrophobic nature, ability to promote percutaneous substance delivery and ease of production.
9 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION BASED ON LECITHINE | 2016 |
|
RU2620250C1 |
PHOSPHOLIPID COMPOSITION | 2010 |
|
RU2448731C2 |
LECITHIN ORGANOGEL | 1998 |
|
RU2155604C2 |
LIQUID CRYSTALLINE COMPOSITION FOR TRANSDERMAL DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES | 2016 |
|
RU2623210C1 |
PERIPHERY BLOOD CIRCULATION IMPROVING REMEDY | 2003 |
|
RU2246934C2 |
OPHTHALMOLOGICAL COMPOSITION, BASED ON POLYUNSATURATED FATTY ACIDS OMEGA-3 AND OMEGA-6 | 2010 |
|
RU2545675C2 |
2-CYCLOALKYLAMINO-5-THIENYL-1,3,4-THIADIAZINES, HYDROBROMIDES, WITH ANTIAGGREGANT ACTIVITY | 2008 |
|
RU2379306C1 |
2-PIPERIDINO-5-(THIENYL-2)- AND 2-PIPERIDINO-5-(THIENYL-3)- 6H-1,3,4-THIADIAZINES HYDROBROMIDES POSSESSING ANTIAGGREGANT ACTION | 2010 |
|
RU2445310C2 |
POLYUNSATURATED FATTY ACID MIXTURE "OMEGA-3" | 1995 |
|
RU2127115C1 |
METHOD FOR PREVENTION OF OXIDATIVE STRESS ACCOMPANYING ADMINISTRATION OF RELEASING-HORMONE CONTRACEPTIVE SYSTEM | 2014 |
|
RU2563178C1 |
Authors
Dates
2009-09-10—Published
2008-06-26—Filed